Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Albariño CG[au]:

Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection. Davis CW et al. Cell. (2019)

Equine Encephalosis Virus in India, 2008. Yadav PD et al. Emerg Infect Dis. (2018)

Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates. Smith DR et al. PLoS Negl Trop Dis. (2018)

Search results

Items: 1 to 50 of 83

1.

Experimental infection of Egyptian rousette bats (Rousettus aegyptiacus) with Sosuga virus demonstrates potential transmission routes for a bat-borne human pathogenic paramyxovirus.

Amman BR, Schuh AJ, Sealy TK, Spengler JR, Welch SR, Kirejczyk SGM, Albariño CG, Nichol ST, Towner JS.

PLoS Negl Trop Dis. 2020 Mar 2;14(3):e0008092. doi: 10.1371/journal.pntd.0008092. eCollection 2020 Mar.

2.

Isolation and phylogenomic analysis of buffalopox virus from human and buffaloes in India.

Yadav PD, Mauldin MR, Nyayanit DA, Albariño CG, Sarkale P, Shete A, Guerrero LW, Nakazawa Y, Nichol ST, Mourya DT.

Virus Res. 2020 Feb;277:197836. doi: 10.1016/j.virusres.2019.197836. Epub 2019 Dec 9.

PMID:
31821842
3.

Rousette Bat Dendritic Cells Overcome Marburg Virus-Mediated Antiviral Responses by Upregulation of Interferon-Related Genes While Downregulating Proinflammatory Disease Mediators.

Prescott J, Guito JC, Spengler JR, Arnold CE, Schuh AJ, Amman BR, Sealy TK, Guerrero LW, Palacios GF, Sanchez-Lockhart M, Albariño CG, Towner JS.

mSphere. 2019 Dec 4;4(6). pii: e00728-19. doi: 10.1128/mSphere.00728-19.

4.

Lassa virus circulating in Liberia: a retrospective genomic characterisation.

Wiley MR, Fakoli L, Letizia AG, Welch SR, Ladner JT, Prieto K, Reyes D, Espy N, Chitty JA, Pratt CB, Di Paola N, Taweh F, Williams D, Saindon J, Davis WG, Patel K, Holland M, Negrón D, Ströher U, Nichol ST, Sozhamannan S, Rollin PE, Dogba J, Nyenswah T, Bolay F, Albariño CG, Fallah M, Palacios G.

Lancet Infect Dis. 2019 Dec;19(12):1371-1378. doi: 10.1016/S1473-3099(19)30486-4. Epub 2019 Oct 3.

PMID:
31588039
5.

Corrigendum: Identification and characterization of novel mosquito-borne (Kammavanpettai virus) and tick-borne (Wad Medani) reoviruses isolated in India.

Yadav PD, Shete AM, Nyayanit DA, Albarino CG, Jain S, Guerrero LW, Kumar S, Patil DY, Nichol ST, Mourya DT.

J Gen Virol. 2019 Sep;100(9):1340. doi: 10.1099/jgv.0.001127. No abstract available.

PMID:
31481150
6.

Protection From Lethal Lassa Disease Can Be Achieved Both Before and After Virus Exposure by Administration of Single-Cycle Replicating Lassa Virus Replicon Particles.

Kainulainen MH, Spengler JR, Welch SR, Coleman-McCray JD, Harmon JR, Scholte FEM, Goldsmith CS, Nichol ST, Albariño CG, Spiropoulou CF.

J Infect Dis. 2019 Sep 13;220(8):1281-1289. doi: 10.1093/infdis/jiz284.

PMID:
31152662
7.

Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection.

Davis CW, Jackson KJL, McElroy AK, Halfmann P, Huang J, Chennareddy C, Piper AE, Leung Y, Albariño CG, Crozier I, Ellebedy AH, Sidney J, Sette A, Yu T, Nielsen SCA, Goff AJ, Spiropoulou CF, Saphire EO, Cavet G, Kawaoka Y, Mehta AK, Glass PJ, Boyd SD, Ahmed R.

Cell. 2019 May 30;177(6):1566-1582.e17. doi: 10.1016/j.cell.2019.04.036. Epub 2019 May 16.

8.

Antibody-Mediated Virus Neutralization Is Not a Universal Mechanism of Marburg, Ebola, or Sosuga Virus Clearance in Egyptian Rousette Bats.

Schuh AJ, Amman BR, Sealy TK, Kainulainen MH, Chakrabarti AK, Guerrero LW, Nichol ST, Albarino CG, Towner JS.

J Infect Dis. 2019 May 5;219(11):1716-1721. doi: 10.1093/infdis/jiy733.

9.

Complete Genome Sequences of Monongahela Hantavirus from Pennsylvania, USA.

Albariño CG, Wiggleton Guerrero L, Chakrabarti AK, Rollin PE, Nichol ST.

Microbiol Resour Announc. 2018 Sep 20;7(11). pii: e00928-18. doi: 10.1128/MRA.00928-18. eCollection 2018 Sep.

10.

Transcriptional analysis of viral mRNAs reveals common transcription patterns in cells infected by five different filoviruses.

Albariño CG, Wiggleton Guerrero L, Chakrabarti AK, Nichol ST.

PLoS One. 2018 Aug 2;13(8):e0201827. doi: 10.1371/journal.pone.0201827. eCollection 2018.

11.

Case Report: Imported Case of Lassa Fever - New Jersey, May 2015.

Kulkarni PA, Chew D, Youssef-Bessler M, Hamdi HA, Montoya LA, Cervantes KB, Mazur NL, Lucas D, Wells JW, Cennimo D, Sutherland A, Di Domenico LM, Miller LP, Pierre-Louis F, Rokosz G, Nazir A, de Perio MA, Lowe L, Manning C, Mead KR, Christensen BE, Albariño CG, Ströher U, Glover M, Lifshitz EI, Tan CG, Rollin PE, Semple S.

Am J Trop Med Hyg. 2018 Oct;99(4):1062-1065. doi: 10.4269/ajtmh.17-0316.

12.

The S Genome Segment Is Sufficient to Maintain Pathogenicity in Intra-Clade Lassa Virus Reassortants in a Guinea Pig Model.

Welch SR, Scholte FEM, Albariño CG, Kainulainen MH, Coleman-McCray JD, Guerrero LW, Chakrabarti AK, Klena JD, Nichol ST, Spengler JR, Spiropoulou CF.

Front Cell Infect Microbiol. 2018 Jul 11;8:240. doi: 10.3389/fcimb.2018.00240. eCollection 2018.

13.

Identification and characterization of novel mosquito-borne (Kammavanpettai virus) and tick-borne (Wad Medani) reoviruses isolated in India.

Yadav PD, Shete AM, Nyayanit DA, Albarino CG, Jain S, Guerrero LW, Kumar S, Patil DY, Nichol ST, Mourya DT.

J Gen Virol. 2018 Aug;99(8):991-1000. doi: 10.1099/jgv.0.001102. Epub 2018 Jun 25. Erratum in: J Gen Virol. 2019 Sep;100(9):1340.

PMID:
29939123
14.

Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model.

Kainulainen MH, Spengler JR, Welch SR, Coleman-McCray JD, Harmon JR, Klena JD, Nichol ST, Albariño CG, Spiropoulou CF.

J Infect Dis. 2018 May 25;217(12):1957-1966. doi: 10.1093/infdis/jiy123.

15.

Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.

Smith DR, Johnston SC, Piper A, Botto M, Donnelly G, Shamblin J, Albariño CG, Hensley LE, Schmaljohn C, Nichol ST, Bird BH.

PLoS Negl Trop Dis. 2018 May 9;12(5):e0006474. doi: 10.1371/journal.pntd.0006474. eCollection 2018 May.

16.

Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.

Shrivastava-Ranjan P, Flint M, Bergeron É, McElroy AK, Chatterjee P, Albariño CG, Nichol ST, Spiropoulou CF.

mBio. 2018 May 1;9(3). pii: e00660-18. doi: 10.1128/mBio.00660-18.

17.

Equine Encephalosis Virus in India, 2008.

Yadav PD, Albariño CG, Nyayanit DA, Guerrero L, Jenks MH, Sarkale P, Nichol ST, Mourya DT.

Emerg Infect Dis. 2018 May;24(5):898-901. doi: 10.3201/eid2405.171844.

18.

Complete Genome Sequences of a Hantavirus Isolate from New York.

McMullan LK, Albariño CG, Ksiazek TG, Nichol ST, Spiropoulou CF.

Genome Announc. 2018 Mar 22;6(12). pii: e00188-18. doi: 10.1128/genomeA.00188-18.

19.

Development of a reverse genetics system for Sosuga virus allows rapid screening of antiviral compounds.

Welch SR, Chakrabarti AK, Wiggleton Guerrero L, Jenks HM, Lo MK, Nichol ST, Spiropoulou CF, Albariño CG.

PLoS Negl Trop Dis. 2018 Mar 9;12(3):e0006326. doi: 10.1371/journal.pntd.0006326. eCollection 2018 Mar.

20.

Genome Sequences of Crimean-Congo Hemorrhagic Fever Virus Strains Isolated in South Africa, Namibia, and Turkey.

Zivcec M, Albarino CG, Guerrero LIW, Ksiazek TG, Nichol ST, Swanepoel R, Rollin PE, Spiropoulou CF.

Genome Announc. 2017 Oct 19;5(42). pii: e01060-17. doi: 10.1128/genomeA.01060-17.

21.

Rapid Determination of Ebolavirus Infectivity in Clinical Samples Using a Novel Reporter Cell Line.

Kainulainen MH, Nichol ST, Albariño CG, Spiropoulou CF.

J Infect Dis. 2017 Dec 12;216(11):1380-1385. doi: 10.1093/infdis/jix486.

22.

Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.

Zivcec M, Guerrero LIW, Albariño CG, Bergeron É, Nichol ST, Spiropoulou CF.

Antiviral Res. 2017 Oct;146:112-120. doi: 10.1016/j.antiviral.2017.08.014. Epub 2017 Aug 24.

PMID:
28842265
23.

Insights into Reston virus spillovers and adaption from virus whole genome sequences.

Albariño CG, Wiggleton Guerrero L, Jenks HM, Chakrabarti AK, Ksiazek TG, Rollin PE, Nichol ST.

PLoS One. 2017 May 25;12(5):e0178224. doi: 10.1371/journal.pone.0178224. eCollection 2017.

24.

25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation.

Shrivastava-Ranjan P, Bergeron É, Chakrabarti AK, Albariño CG, Flint M, Nichol ST, Spiropoulou CF.

mBio. 2016 Dec 20;7(6). pii: e01808-16. doi: 10.1128/mBio.01808-16.

25.

Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system.

Guito JC, Albariño CG, Chakrabarti AK, Towner JS.

Virology. 2017 Jan 15;501:147-165. doi: 10.1016/j.virol.2016.11.015. Epub 2016 Dec 6.

26.

Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems.

Welch SR, Guerrero LW, Chakrabarti AK, McMullan LK, Flint M, Bluemling GR, Painter GR, Nichol ST, Spiropoulou CF, Albariño CG.

Antiviral Res. 2016 Dec;136:9-18. doi: 10.1016/j.antiviral.2016.10.007. Epub 2016 Oct 19.

PMID:
27771389
27.

Virus fitness differences observed between two naturally occurring isolates of Ebola virus Makona variant using a reverse genetics approach.

Albariño CG, Guerrero LW, Chakrabarti AK, Kainulainen MH, Whitmer SLM, Welch SR, Nichol ST.

Virology. 2016 Sep;496:237-243. doi: 10.1016/j.virol.2016.06.011. Epub 2016 Jun 29.

28.

Prognostic Indicators for Ebola Patient Survival.

Crowe SJ, Maenner MJ, Kuah S, Erickson BR, Coffee M, Knust B, Klena J, Foday J, Hertz D, Hermans V, Achar J, Caleo GM, Van Herp M, Albariño CG, Amman B, Basile AJ, Bearden S, Belser JA, Bergeron E, Blau D, Brault AC, Campbell S, Flint M, Gibbons A, Goodman C, McMullan L, Paddock C, Russell B, Salzer JS, Sanchez A, Sealy T, Wang D, Saffa G, Turay A, Nichol ST, Towner JS.

Emerg Infect Dis. 2016 Feb;22(2):217-23. doi: 10.3201/eid2202.151250.

29.

Assessment of Inhibitors of Pathogenic Crimean-Congo Hemorrhagic Fever Virus Strains Using Virus-Like Particles.

Zivcec M, Metcalfe MG, Albariño CG, Guerrero LW, Pegan SD, Spiropoulou CF, Bergeron É.

PLoS Negl Trop Dis. 2015 Dec 1;9(12):e0004259. doi: 10.1371/journal.pntd.0004259. eCollection 2015 Dec.

30.

Comparison of FilmArray and Quantitative Real-Time Reverse Transcriptase PCR for Detection of Zaire Ebolavirus from Contrived and Clinical Specimens.

Southern TR, Racsa LD, Albariño CG, Fey PD, Hinrichs SH, Murphy CN, Herrera VL, Sambol AR, Hill CE, Ryan EL, Kraft CS, Campbell S, Sealy TK, Schuh A, Ritchie JC, Lyon GM 3rd, Mehta AK, Varkey JB, Ribner BS, Brantly KP, Ströher U, Iwen PC, Burd EM.

J Clin Microbiol. 2015 Sep;53(9):2956-60. doi: 10.1128/JCM.01317-15. Epub 2015 Jul 8.

31.

Development of a reverse genetics system to generate a recombinant Ebola virus Makona expressing a green fluorescent protein.

Albariño CG, Wiggleton Guerrero L, Lo MK, Nichol ST, Towner JS.

Virology. 2015 Oct;484:259-64. doi: 10.1016/j.virol.2015.06.013. Epub 2015 Jun 27.

32.

Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses.

Mohr EL, McMullan LK, Lo MK, Spengler JR, Bergeron É, Albariño CG, Shrivastava-Ranjan P, Chiang CF, Nichol ST, Spiropoulou CF, Flint M.

Antiviral Res. 2015 Aug;120:40-7. doi: 10.1016/j.antiviral.2015.05.003. Epub 2015 May 16.

33.

Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States.

Liddell AM, Davey RT Jr, Mehta AK, Varkey JB, Kraft CS, Tseggay GK, Badidi O, Faust AC, Brown KV, Suffredini AF, Barrett K, Wolcott MJ, Marconi VC, Lyon GM 3rd, Weinstein GL, Weinmeister K, Sutton S, Hazbun M, Albariño CG, Reed Z, Cannon D, Ströher U, Feldman M, Ribner BS, Lane HC, Fauci AS, Uyeki TM.

Ann Intern Med. 2015 Jul 21;163(2):81-90. doi: 10.7326/M15-0530.

34.

Recovery of Recombinant Crimean Congo Hemorrhagic Fever Virus Reveals a Function for Non-structural Glycoproteins Cleavage by Furin.

Bergeron É, Zivcec M, Chakrabarti AK, Nichol ST, Albariño CG, Spiropoulou CF.

PLoS Pathog. 2015 May 1;11(5):e1004879. doi: 10.1371/journal.ppat.1004879. eCollection 2015 May.

35.

A Recently Discovered Pathogenic Paramyxovirus, Sosuga Virus, is Present in Rousettus aegyptiacus Fruit Bats at Multiple Locations in Uganda.

Amman BR, Albariño CG, Bird BH, Nyakarahuka L, Sealy TK, Balinandi S, Schuh AJ, Campbell SM, Ströher U, Jones ME, Vodzack ME, Reeder DM, Kaboyo W, Nichol ST, Towner JS.

J Wildl Dis. 2015 Jul;51(3):774-9. doi: 10.7589/2015-02-044. Epub 2015 Apr 28.

36.

Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of Host immune responses.

Albariño CG, Wiggleton Guerrero L, Spengler JR, Uebelhoer LS, Chakrabarti AK, Nichol ST, Towner JS.

Virology. 2015 Feb;476:85-91. doi: 10.1016/j.virol.2014.12.002. Epub 2014 Dec 19.

37.

Small interfering RNA inhibition of Andes virus replication.

Chiang CF, Albariňo CG, Lo MK, Spiropoulou CF.

PLoS One. 2014 Jun 12;9(6):e99764. doi: 10.1371/journal.pone.0099764. eCollection 2014.

38.

High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses.

Uebelhoer LS, Albariño CG, McMullan LK, Chakrabarti AK, Vincent JP, Nichol ST, Towner JS.

Antiviral Res. 2014 Jun;106:86-94. doi: 10.1016/j.antiviral.2014.03.018. Epub 2014 Apr 5.

39.

Hantavirus infections among overnight visitors to Yosemite National Park, California, USA, 2012.

Núñez JJ, Fritz CL, Knust B, Buttke D, Enge B, Novak MG, Kramer V, Osadebe L, Messenger S, Albariño CG, Ströher U, Niemela M, Amman BR, Wong D, Manning CR, Nichol ST, Rollin PE, Xia D, Watt JP, Vugia DJ; Yosemite Hantavirus Outbreak Investigation Team.

Emerg Infect Dis. 2014 Mar;20(3):386-93. doi: 10.3201/eid2003.131581.

40.

Lymphocytic choriomeningitis virus in employees and mice at multipremises feeder-rodent operation, United States, 2012.

Knust B, Ströher U, Edison L, Albariño CG, Lovejoy J, Armeanu E, House J, Cory D, Horton C, Fowler KL, Austin J, Poe J, Humbaugh KE, Guerrero L, Campbell S, Gibbons A, Reed Z, Cannon D, Manning C, Petersen B, Metcalf D, Marsh B, Nichol ST, Rollin PE.

Emerg Infect Dis. 2014 Feb;20(2):240-7. doi: 10.3201/eid2002.130860.

41.

Novel paramyxovirus associated with severe acute febrile disease, South Sudan and Uganda, 2012.

Albariño CG, Foltzer M, Towner JS, Rowe LA, Campbell S, Jaramillo CM, Bird BH, Reeder DM, Vodzak ME, Rota P, Metcalfe MG, Spiropoulou CF, Knust B, Vincent JP, Frace MA, Nichol ST, Rollin PE, Ströher U.

Emerg Infect Dis. 2014 Feb;20(2):211-6. doi: 10.3201/eid2002.131620.

42.

Development of a reverse genetics system to generate recombinant Marburg virus derived from a bat isolate.

Albariño CG, Uebelhoer LS, Vincent JP, Khristova ML, Chakrabarti AK, McElroy A, Nichol ST, Towner JS.

Virology. 2013 Nov;446(1-2):230-7. doi: 10.1016/j.virol.2013.07.038. Epub 2013 Sep 5.

43.

Genomic analysis of filoviruses associated with four viral hemorrhagic fever outbreaks in Uganda and the Democratic Republic of the Congo in 2012.

Albariño CG, Shoemaker T, Khristova ML, Wamala JF, Muyembe JJ, Balinandi S, Tumusiime A, Campbell S, Cannon D, Gibbons A, Bergeron E, Bird B, Dodd K, Spiropoulou C, Erickson BR, Guerrero L, Knust B, Nichol ST, Rollin PE, Ströher U.

Virology. 2013 Aug 1;442(2):97-100. doi: 10.1016/j.virol.2013.04.014. Epub 2013 May 25.

44.

Severe hemorrhagic fever in strain 13/N guinea pigs infected with Lujo virus.

Bird BH, Dodd KA, Erickson BR, Albariño CG, Chakrabarti AK, McMullan LK, Bergeron E, Ströeher U, Cannon D, Martin B, Coleman-McCray JD, Nichol ST, Spiropoulou CF.

PLoS Negl Trop Dis. 2012;6(8):e1801. doi: 10.1371/journal.pntd.0001801. Epub 2012 Aug 28.

45.

A new phlebovirus associated with severe febrile illness in Missouri.

McMullan LK, Folk SM, Kelly AJ, MacNeil A, Goldsmith CS, Metcalfe MG, Batten BC, Albariño CG, Zaki SR, Rollin PE, Nicholson WL, Nichol ST.

N Engl J Med. 2012 Aug 30;367(9):834-41. doi: 10.1056/NEJMoa1203378.

46.

Reverse genetics recovery of Lujo virus and role of virus RNA secondary structures in efficient virus growth.

Bergeron É, Chakrabarti AK, Bird BH, Dodd KA, McMullan LK, Spiropoulou CF, Nichol ST, Albariño CG.

J Virol. 2012 Oct;86(19):10759-65. doi: 10.1128/JVI.01144-12. Epub 2012 Jul 25.

47.

Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge.

Dodd KA, Bird BH, Metcalfe MG, Nichol ST, Albariño CG.

J Virol. 2012 Apr;86(8):4204-12. doi: 10.1128/JVI.07104-11. Epub 2012 Feb 15.

48.

Development of a novel nonhuman primate model for Rift Valley fever.

Smith DR, Bird BH, Lewis B, Johnston SC, McCarthy S, Keeney A, Botto M, Donnelly G, Shamblin J, Albariño CG, Nichol ST, Hensley LE.

J Virol. 2012 Feb;86(4):2109-20. doi: 10.1128/JVI.06190-11. Epub 2011 Dec 7.

49.

Ancient ancestry of KFDV and AHFV revealed by complete genome analyses of viruses isolated from ticks and mammalian hosts.

Dodd KA, Bird BH, Khristova ML, Albariño CG, Carroll SA, Comer JA, Erickson BR, Rollin PE, Nichol ST.

PLoS Negl Trop Dis. 2011 Oct;5(10):e1352. doi: 10.1371/journal.pntd.0001352. Epub 2011 Oct 4.

50.

Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.

Bird BH, Maartens LH, Campbell S, Erasmus BJ, Erickson BR, Dodd KA, Spiropoulou CF, Cannon D, Drew CP, Knust B, McElroy AK, Khristova ML, Albariño CG, Nichol ST.

J Virol. 2011 Dec;85(24):12901-9. doi: 10.1128/JVI.06046-11. Epub 2011 Oct 5.

Supplemental Content

Loading ...
Support Center